Stock EGRX EAGLE PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eagle Pharmaceuticals, Inc.

Equities

EGRX

US2697961082

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.47 USD +1.31% Intraday chart for Eagle Pharmaceuticals, Inc. -7.22% -33.65%
May. 15 Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement CI
May. 06 North American Morning Briefing : Stock Futures -2- DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stock Futures -2-
DJ
Piper Sandler Downgrades Eagle Pharmaceuticals to Underweight From Neutral, Adjusts Price Target to $17 From $26
MT
Cantor Fitzgerald Adjusts Eagle Pharmaceuticals Price Target to $33 From $37, Maintains Neutral Rating
MT
Cantor Fitzgerald Adjusts Eagle Pharmaceuticals Price Target to $37 From $45, Maintains Neutral Rating
MT
FTSE 100 Rises, 10Y Gilt Yields Hit Six-Year High as Interest-Rate Rises Loom
DJ
EAGLE PHARMACEUTICALS : RBC Trims Price Target on Eagle Pharmaceuticals to $50 From $52, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EGRX Stock
  4. News Eagle Pharmaceuticals, Inc.
  5. Analyst Reco.